Press releases

Filter
19 found

MMV and LSTM collaborate to fill data gap on use of antimalarials during pregnancy

08 Mar 2020
Laboratory image

Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million

27 Nov 2019

Country leaders pledge to boost malaria innovation and access to new and existing antimalarials

11 Nov 2019

MMV and Novartis expand partnership

15 Jun 2016

Pyramax® Granules becomes first paediatric antimalarial to receive EMA Article 58 positive scientific opinion

20 Nov 2015

GHIT invests $10.7 million in malaria, TB, leishmaniasis and dengue research

05 Nov 2015

New compound has the potential to treat malaria patients in a single dose

17 Jun 2015

GHIT, Takeda and MMV progress first-in-class antimalarial DSM265 to patient trials in Peruvian Amazon

05 Jun 2015

Merck Serono and MMV sign agreement to develop potential antimalarial therapy

01 Apr 2015

Partnership reaches important milestone

14 Nov 2011

Antimalarial drug discovery urgently needs prioritised 5-year plan to avoid missing opportunities

11 Oct 2011

Molecule moves through preclinical development in record time

02 Sep 2011

Sanofi-aventis and MMV join forces to develop innovative malaria drugs

05 May 2011

Anacor Pharmaceuticals and MMV sign agreement to pursue promising compound for malaria

18 Mar 2011

Jomaa Pharma and MMV to co-develop novel malaria treatment based on fosmidomycin

15 Feb 2011

Single-dose cure for malaria edges closer to the clinic

08 Feb 2011

MMV and Anacor join hands in hunt for new antimalarial compounds

26 Apr 2010

MMV supports trials of a new preventive treatment option for pregnant women

23 Apr 2010

Pyramax® submitted to EMA for regulatory approval

08 Apr 2010